This study evaluated the effect of onion extract on corneal haze suppression after applying the air assisted lamellar keratectomy. The air assisted lamellar keratectomy was performed on 24 canine eyes. They were treated with an artificial tear (group C), prednisolone acetate (group P), onion extract (group O) and TGF-β1 (group T) three times per day from 7 to 28 days after the surgery. Corneal haze occurred on the all eyes and was observed beginning 7 days after the surgery. The haze was significantly decreased in groups P and O from day 14 compared with the group C using the clinical (group P; P=0.021, group O; P=0.037) and objective evaluation method (group P; P=0.021, group O; P=0.039). In contrast, it was significantly increased in group T from day 14 compared with group C based on the clinical (P=0.002) and objective evaluation method (P<0.001). Subsequently, these eyes were enucleated after euthanasia, and immunohistochemistry with α-SMA antibodies was done. The total green intensity for α-SMA was significantly more expressed in group T and significantly less expressed in groups P and O than in group C. Onion extract could have potential as a therapeutic in preventing corneal haze development by suppressing the differentiation of fibroblasts into myofibroblasts.
This study evaluated the effect of onion extract on corneal haze suppression after applying the air assisted lamellar keratectomy. The air assisted lamellar keratectomy was performed on 24 canine eyes. They were treated with an artificial tear (group C), prednisolone acetate (group P), onion extract (group O) and TGF-β1 (group T) three times per day from 7 to 28 days after the surgery. Corneal haze occurred on the all eyes and was observed beginning 7 days after the surgery. The haze was significantly decreased in groups P and O from day 14 compared with the group C using the clinical (group P; P=0.021, group O; P=0.037) and objective evaluation method (group P; P=0.021, group O; P=0.039). In contrast, it was significantly increased in group T from day 14 compared with group C based on the clinical (P=0.002) and objective evaluation method (P<0.001). Subsequently, these eyes were enucleated after euthanasia, and immunohistochemistry with α-SMA antibodies was done. The total green intensity for α-SMA was significantly more expressed in group T and significantly less expressed in groups P and O than in group C. Onion extract could have potential as a therapeutic in preventing corneal haze development by suppressing the differentiation of fibroblasts into myofibroblasts.
Many corneal diseases are associated with the development of opacities in the stroma. Corneal
haze presents as a superficial opacification of the anterior corneal stroma leading to a
transient decrease in corneal transparency after lamellar keratectomy for dermoid, corneal
inclusion cyst and corneal tumor, corneoconjunctival transposition or autologous lamellar
keratoplasty for deep corneal ulcer in veterinary ophthalmology. Also, it is one of the most
important complications of photorefractive keratectomy (PRK), and its incidence and intensity
increase in eyes treated for higher degrees of refractive error in human medicine [12]. In most transparency disorders, corneal haze may be
induced by a combination of two or more predominant factors like corneal edema, scarring,
accumulated macromolecules and reflective keratocytes [23]. Moreover, the formation of corneal haze involves the apoptosis of keratocytes
and the proliferation and transformation of fibroblasts into myofibroblasts [30]. Therefore, one of the most crucial aspects of corneal
healing from refractive surgery is the minimization of corneal haze.The efficacy of mitomycin C (MMC) in reducing the incidence of corneal haze has led to its
widespread use in most refractive surgery practices [29]. However, multiple complications, such as limbal/scleral necrosis, abnormal wound
healing and loss of keratocytes, are reported with the topical use of MMC [25]. These results encourage the development of newer
pharmacologic agents that can effectively inhibit the formation of corneal haze without
causing serious side effects. Recent research on trichostatin A (TSA), a histone deacetylase
inhibitor, reported that it inhibits TGF-β1-induced accumulation of the extracellular matrix
and myofibroblast formation in vitro and markedly decreases haze in
vivo [28]. However, there are no
commercially available products for clinical use.Allium cepa (onion) and onion extract have been reported to be effective in
cardiovascular disease, because of their hypolipidemic, anti-hypertensive, anti-diabetic and
antithrombotic effects, and to possess many other biological activities including
antimicrobial, antioxidant, anticarcinogenic and immunomodulatory activities [6]. Especially, flavonoids in onion extract reduce scar
formation by inhibiting fibroblast activities [4].
Recently, commercial products composed of onion extract have been used to reduce hypertrophic
scar formation [13]. Myofibroblasts are an important
cell in connective tissue remodeling that differentiates during wound healing and fibrosis
development in the pathogenesis of such diseases as hypertrophic scars, liver or pulmonary
fibrosis [8], and corneal haze formation [20]. The myofibroblasts could represent an important target
for corneal haze treatment like in the treatment for hypertrophic scar formation. Thus, onion
extract could be useful as a therapeutic in preventing the development of corneal haze by
suppressing the differentiation of fibroblasts into myofibroblasts.Air assisted lamellar keratectomy is one of the experimental models for the development of
corneal haze [18]. In this method, the wound size and
depth were standardized by modification of the bubble technique for corneal transplantation.
Also, it could induce more corneal haze than the conventional superficial keratectomy.The aim of this study was to evaluate the efficacy of onion extract ointment in corneal haze
development after applying to the haze model with the air assisted lamellar keratectomy for
canine eyes. In addition, the effect of onion extract ointment in the down-regulation of
myofibroblast expression was examined with immunohistochemistry using the α-SMA antibody.
MATERIALS AND METHODS
Corneal fibroblast culture and cell viability test for onion extract:
Corneal fibroblasts were cultured from porcine eyes, which were obtained from a local
slaughterhouse, for the cell viability test of the onion extract. The corneal buttons
removed by an 8-mm diameter trephine (Barron radial vacuum trephine, Katena products, Inc.,
Denvile, NJ, U.S.A.) were obtained. After then, the epithelial cells of the corneal buttons
were scrapped off using a #10 scalpel blade, Descemet’s membranes were peeled off, and the
corneal stromas were washed with phosphate buffered saline (PBS, pH 7.4) (10010-023,
GIBCOTM, Grand Island, NY, U.S.A.). The corneal buttons were cut into four
small pieces and incubated overnight in a humidified CO2 incubator at 37°C in
Dulbecco’s modified Eagle’s medium (DMEM) (11995-065, GIBCOTM) containing 20 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 15630-080, GIBCOTM)
and 1.25 mg/ml collagenase type I (17100-017, GIBCOTM). The
digested tissues were mixed with media by pipetting and filtered a 100 µm
cell strainer (08-771-19, FalconTM, Franklin Lakes, NJ, U.S.A.). Then, they were
centrifuged at 800 g for 5 min and resuspended in 2 ml of DMEM containing
20 mM HEPES, 50 µg/ml gentamicin (15750-078,
GIBCOTM), 1.25 µg/ml amphotericin B (A20678,
GIBCOTM) and 10% fetal bovine serum (10437-028, GIBCOTM). This
keratocyte-containing cell suspension was then seeded on 6-well plastic dishes and incubated
in a humidified CO2 incubator at 37°C. Eighty percent confluent cultures of
cornea fibroblasts (passages 1–3) were used for experiments.Trypan blue dye exclusion test was used to evaluate cell viability of corneal fibroblasts
after treating onion extract. Onion extract (W281719, Sigma-Aldrich, St. Louis, MO, U.S.A.)
was treated to the each well at 0, 0.01, 0.1, 1, 10, 50 and 100
µl/ml concentrations diluted with DMSO (AMR-0231-1;
Amresco, Solon, OH, U.S.A.) for 24 hr. Then, they were resuspended using 0.05% trypsin/0.53
mM EDTA (25300-054, GIBCOTM), and trypan blue solutions (0.4% wt/vol, 15250-061,
GIBCOTM) were mixed with the resuspension cells. The suspensions were loaded
into a hemocytometer and scored with a light microscope. Cells that stained blue were scored
as nonviable.A process of manufacture for the onion extract ointment: A 1% onion
extract ointment was made with 10 g white petrolatum (white petrolatum 1 g/g, Sungkwang
Pharm., Cheonan, Korea) and 0.1 ml onion extract (W281719, Sigma-Aldrich)
mixture in a water bath. The concentration of onion extract ointment depended on the
in vitro viability test. Before use in a main study, the onion extract
ointment was applied BID for 2 weeks at the normal cornea of six healthy beagle dogs to test
the abnormal allergic reactions (blepharospasm, conjunctival hyperemia, corneal epithelial
disorders and other ocular abnormality) by ophthalmic examinations every the other days.Animals: Twenty-four eyes from 12 healthy beagles were used in this study.
Before the experiment, all dogs underwent an ophthalmic examination including slit-lamp
biomicroscopy (SL-D7, Topcon, Tokyo, Japan), indirect ophthalmoscopy (Vantage plus, Keeler,
Windsor, U.K.), rebound tonometry (Tonovet, Tiolat, Helsinki, Finland), Schirmer’s tear test
(Schirmer tear test, Intervet, Summit, NJ, U.S.A.) and fluorescein staining (Fluorescein
paper, Haag Streit AG, Koeniz, Switzerland). Dogs with ocular or systemic diseases were
excluded. The animal use and experimental protocols were approved by the Institutional
Animal Care and Use committee (SNU-121123-10; Seoul National University, Korea). All dogs
were divided into 4 groups consisting of 6 eyes in each group; control (Group C; n=6),
Prednisolone acetate treatment (Group P; n=6), Onion extract treatment (Group O; n=6) and
TGF-β1 treatment (Group T; n=6).Corneal Haze Generation by the air assisted lamellar keratectomy: Air
assisted lamellar keratectomy was performed following a method reported previously [18]. General anesthesia was accomplished by intravenous
injection of tiletamine and zolazepam (Zoletil, Virbac, Carros, France; 2.5 mg/kg) for
induction and maintained with isoflurane (Ifran, Hana Pharm, Seoul, Korea; MAC 0.5–1.5%).
Atracurium (ATRA, Hana Pharm; 0.01 mg/kg, IV) was administrated for central positioning of
the cornea during the surgery. The air assisted lamellar keratectomy was performed for all
eyes. Briefly, the center of the cornea was trephined 375 µm using an 8 mm
diameter trephine (Barron radial vacuum trephine, Katena) (Fig. 1A). The surgical field was kept dry after the trephination to minimize stromal edema.
Four ml of air were injected at the base of the trephination gutter into
the corneal stroma using a 30-gauge needle attached to a syringe. The needle was bent 5 mm
from its tip so that the terminal segment angled upwards approximately 60°, while the bevel
faces up (Fig. 1B). The tip was introduced
parallel to the corneal surface into the central stroma at the base of the trephination
groove. The plunger of the air-filled syringe was pressed until intrastromal blanching was
observed (Fig. 1C). The fuzzy region of the white
opaque cornea was removed using a corneal dissector and blunt-tipped corneal scissors (Fig. 1D).
Fig. 1.
The air assisted lamellar keratectomy. (A) The center of the cornea was trephined 375
µm using an 8 mm vacuum trephine. (B) Four ml of
air was injected at the base of the trephination gutter into the corneal stroma using
a 30-gauge needle attached to a syringe. (C) Intrastromal blanching was observed, and
the blanched cornea was removed using a corneal dissector and blunt-tipped corneal
scissors. (D) Appearance after keratectomy using the air assisted lamellar
keratectomy.
The air assisted lamellar keratectomy. (A) The center of the cornea was trephined 375
µm using an 8 mm vacuum trephine. (B) Four ml of
air was injected at the base of the trephination gutter into the corneal stroma using
a 30-gauge needle attached to a syringe. (C) Intrastromal blanching was observed, and
the blanched cornea was removed using a corneal dissector and blunt-tipped corneal
scissors. (D) Appearance after keratectomy using the air assisted lamellar
keratectomy.After surgery, one drop of atropine (1%, Isopto Atropine, Alcon, Antwerp, Belgium) was
applied for 3 days for the purpose of analgesic effect. Levofloxacine (0.5%, Cravit, Santen,
Osaka, Japan) eye drops were administered three times daily until 7 days after the surgery.
After the seventh day, artificial tear eye drops (0.1% sodium hyaluronate; Lacure, Samil
Pharm., Seoul, Korea) for group C, prednisolone acetate 1% (Pred-Forte, Allergan, Irvine,
CA, U.S.A.) for group P, an onion extract (W281719, Sigma-Aldrich, St. Louis, MO, U.S.A.)
ointment 10 ml/mg diluted with a white petrolatum (Vaseline, SungKwang
Pharm, Cheonan, Korea) for group O and TGF-β1 (T7039, Sigma-Aldrich) 1
ng/ml diluted with artificial tear eye drops for group T
were administered 3 times daily each for 3 weeks. Corneal Haze Grading: The
level of haze in the cornea was evaluated by slit lamp biomicroscopy (SL-D7) at 7, 14, 21
and 28 days after the surgery using two kinds of methods: the previously reported clinical
grading system [10] and a quantitative method. With
the clinical grading, grade 0 was a completely clear cornea; grade 0.5 had a trace amount of
haze observed with careful oblique illumination; grade 1 was a mild obscuration of the iris
details; grade 2 was a more prominent haze not interfering with the visibility of fine iris
details; grade 3 was a moderate obscuration of the iris and lens; and grade 4 was complete
opacification of the stroma in the area of the ablation. Haze grading was performed in a
blinded manner by three independent veterinarians.For quantitative haze grading, slit images were taken under standardized conditions: a 1 mm
wide, 14 mm long slit beam and a 45° angle from the temporal aspect of the cornea without
background illumination. Then, each photograph was converted into an 8 bit gray-scale image
using digital image analysis (ImageJ ver. 1.46r; http://rsbweb.nih.gov/ij/). The selected
area of the corneal section (100 × 3 pixel) was isolated, and an intensity of 0 to 255 was
determined by averaging the gray-scale (intensity) indices of the individual pixels within
the area. Total intensity levels within the selected area were measured.Immunofluorescence Analyses: The beagle eyes were enucleated with the
conventional trans-scleral method after euthanasia. Corneas were excised 2–3 mm from the
limbus with forceps and tenotomy scissors. And then, the samples were fixed in 10% buffered
formalin and embedded in paraffin. Immunofluorescence staining for α-smooth muscle actin
(SMA), a marker for myofibroblasts, was performed. Tissue sections (4 µm)
were incubated at room temperature with the monoclonal antibody for α-SMA (M085101, DAKO,
Carpinteria, CA, U.S.A.) at a 1:200 dilution in 1× PBS for 90 min and with a secondary
antibody (Alexa Fluor 488goat anti-mouse IgG; Molecular Probes, Eugene, OR, U.S.A.) at a
dilution of 1:500 for 1 hr. Tissues were mounted with mounting medium and DAPI (SlowFade
Gold antifade reagent, Molecular Probes) to visualize the nuclei in the tissue sections.
Sections were viewed and photographed with a fluorescence microscope (BX51, Olympus, Tokyo,
Japan) equipped with a digital camera (DP71, Olympus).Quantification of α-SMA-positive Cells: The α-SMA positive cells in six
randomly selected, non-overlapping, full-thickness central corneal columns, extending from
the anterior stromal surface to the posterior stromal surface were counted following a
method previously reported [21]. The diameter of each
column was a 400× microscope field. The images were evaluated using digital image
analysis.Statistical Analysis: Statistical analysis was performed with SPSS V20 for
Windows (SPSS Inc., Chicago, IL, U.S.A.). Data were expressed as the mean ± standard
deviation (SD), and the level of significance was P<0.05. One way
analysis of variance (ANOVA) with Bonferroni’s post-hoc assessment was used to test for the
significance of the objective haze grading and the total green color intensity between the
groups. In addition, in one-way repeated measures ANOVA following pairwise comparison,
Bonferroni’s adjustment was performed to evaluate the objective haze grades against time in
the same group. For the clinical corneal haze grading, the values between groups were
compared using the Kruskal-Wallis analysis or Friedman test with the Wilcoxon signed rank
test.
RESULTS
Cell viability was over 95% at the concentration of 0, 0.01, 0.1, 1 and 10
µl/ml onion extract in vitro evaluation
(data not shown). The 1% onion extract ointment showed no adverse effects and allergic
reaction, like blepharospasm, conjunctival hyperemia, corneal epithelial disorders and other
ocular abnormalities, when applied every 12 hr to the normal beagle cornea for 2 weeks.Corneal haze developed after the air assisted lamellar keratectomy depending on each
treatment group (Fig. 2). Control corneas treated with the artificial tear eye drops (group C) had
significant developed corneal haze in clinical grading until 21 days after surgery (day 14;
P=0.032, day 21; P=0.041 and day 28;
P=0.210) compared with day 7 (Fig.
3). Topical application of 1% prednisolone acetate (group P) and 1% onion extract
ointment (group O) caused a statistically significant decrease in corneal haze in group P
(day 14; P=0.021, day 21; P=0.012 and day 28;
P=0.001) and in group O (day 14; P=0.037, day 21;
P=0.008 and day 28; P=0.003) compared with the same
groups for haze grading at day 7. Additionally, corneal haze was significantly increased in
the TGF-β1 treated group (group T) (day 14; P=0.002, day 21;
P<0.001 and day 28; P<0.001 compared with the haze
grading at day 7). For the degree of clinical corneal haze in each group, it decreased in
groups P and O from day 14 (day 14; P=0.016 and P=0.007,
day 21; P<0.001 and P=0.026 and day 28;
P=0.001 and P=0.011, respectively) compared with group
C. In addition, corneal haze significantly increased in group T at days 21
(P=0.022) and 28 (P=0.001) compared with group C.
Fig. 2.
Evaluation of corneal haze with a slit-lamp biomicroscopy. (a) pre-operative
evaluation in control group (group C), (b) 7 days after surgery in the group C, (c) 14
days after surgery in the group C, (d) 21 days after surgery in the group C, (e) 28
days after surgery in the group C, (f) pre-operation in 1% prednisolone acetate
treatment group (group P), (g) 7 days after surgery in the group P, (h) 14 days after
surgery in the group P, (i) 21 days after surgery in the group P, (j) 28 days after
surgery in the group P, (k) pre-operation in 1% onion extract ointment treatment group
(group O), (l) 7 days after surgery in the group O, (m) 14 days after surgery in the
group O, (n) 21 days after surgery in the group O, (o) 28 ays after surgery in the
group O, (p) pre-operation TGF-β1 1 ng/μl treatment
group (group T), (q) 7 days after surgery in the group T, (r) 14 days after surgery in
the group Y, (s) 21 days after surgery in the group T, (t) 28 days after surgery in
the group O.
Fig. 3.
Clinical corneal haze grading. Mean grades for the clinical evaluation of corneal
haze at days 7, 14, 21 and 28 after surgery for each group. a, b, cValues
with a different superscript were significantly different (P<0.05)
between groups in the same evaluation day.
Evaluation of corneal haze with a slit-lamp biomicroscopy. (a) pre-operative
evaluation in control group (group C), (b) 7 days after surgery in the group C, (c) 14
days after surgery in the group C, (d) 21 days after surgery in the group C, (e) 28
days after surgery in the group C, (f) pre-operation in 1% prednisolone acetate
treatment group (group P), (g) 7 days after surgery in the group P, (h) 14 days after
surgery in the group P, (i) 21 days after surgery in the group P, (j) 28 days after
surgery in the group P, (k) pre-operation in 1% onion extract ointment treatment group
(group O), (l) 7 days after surgery in the group O, (m) 14 days after surgery in the
group O, (n) 21 days after surgery in the group O, (o) 28 ays after surgery in the
group O, (p) pre-operation TGF-β1 1 ng/μl treatment
group (group T), (q) 7 days after surgery in the group T, (r) 14 days after surgery in
the group Y, (s) 21 days after surgery in the group T, (t) 28 days after surgery in
the group O.Clinical corneal haze grading. Mean grades for the clinical evaluation of corneal
haze at days 7, 14, 21 and 28 after surgery for each group. a, b, cValues
with a different superscript were significantly different (P<0.05)
between groups in the same evaluation day.Corneal haze was observed beginning 7 days after surgery in all groups and appeared to peak
about 21 days after surgery in the control group with an objective evaluation method. The
total intensity of the grayscale units for the hazed cornea was significantly increased at
days 21 (P<0.001) and 28 (P<0.001) compared with day
7 in group C (Fig. 4). The total intensity in groups P (day 14; P=0.021, day 21;
P<0.001 and day 28; P<0.001) and O (day 14;
P=0.039, day 21; P<0.001 and day 28;
P<0.001) was significantly decreased compared with that at day 7. The
total intensity of the grayscale units in group T was significantly increased at days 14
(P<0.001), 21 (P<0.001) and 28
(P<0.001) compared with that at day 7.
Fig. 4.
Quantification of corneal haze. Total intensity (grayscale unites) levels within the
corneal section at days 7, 14, 21 and 28 after surgery for all groups. a, b,
cValues with a different superscript were significantly different
(P<0.05) between groups in the same evaluation day.
Quantification of corneal haze. Total intensity (grayscale unites) levels within the
corneal section at days 7, 14, 21 and 28 after surgery for all groups. a, b,
cValues with a different superscript were significantly different
(P<0.05) between groups in the same evaluation day.The corneal haze was significantly decreased in groups
P (P<0.001) and O (P<0.001) at day 21,
and in groups P (P<0.001) and O (P=0.002) at day 28
compared with group C. Furthermore, the corneal haze was significantly increased in group T
at days 14 (P<0.001), 21 (P<0.001) and 28
(P=0.003) compared with group C.The results of immunohistochemical staining for α-SMA are shown in Fig. 5. In group C, the corneas exhibited high numbers of α-SMA-positive myofibroblast
cells, mostly in the anterior stroma below the epithelium. Topical application of
prednisolone acetate (group P) and onion extract (group
O) significantly reduced the numbers of α-SMA-positive cells in the stroma. In
contrast, TGF-β1 application (group T) significantly increased the numbers of α-SMA-positive
cells compared with that in group C.
Fig. 5.
Immunohistochemistry for α-smooth muscle actin (SMA) (400× magnification, scale
bar=50 µm). (a) stained nucleus with DAPI in control group (group C),
(b) α-SMA-positive cells (green color) in the group C, (c) merge image a and b, (d)
stained nucleus with DAPI in prednisolone acetate treatment group (group P), (e)
α-SMA-positive cells (green color) in the group P, (f) merge image d and e, (g)
stained nucleus with DAPI in onion extract treatment group (group O), (h)
α-SMA-positive cells (green color) in the group O, (i) merge image g and h, (j)
stained nucleus with DAPI in TGF-β1 treated group group (group T), (k) α-SMA-positive
cells (green color) in the group T, (l) merge image j and k.
Immunohistochemistry for α-smooth muscle actin (SMA) (400× magnification, scale
bar=50 µm). (a) stained nucleus with DAPI in control group (group C),
(b) α-SMA-positive cells (green color) in the group C, (c) merge image a and b, (d)
stained nucleus with DAPI in prednisolone acetate treatment group (group P), (e)
α-SMA-positive cells (green color) in the group P, (f) merge image d and e, (g)
stained nucleus with DAPI in onion extract treatment group (group O), (h)
α-SMA-positive cells (green color) in the group O, (i) merge image g and h, (j)
stained nucleus with DAPI in TGF-β1 treated group group (group T), (k) α-SMA-positive
cells (green color) in the group T, (l) merge image j and k.The total green intensity of the entire stroma was significantly enhanced in group T
(P<0.001) compared with that in group C (Fig. 6). The total green intensity in groups P (P<0.001) and O
(P<0.001) was significantly lower than that in group C.
Fig. 6.
The total intensity of green color was significantly lower in the prednisolone
acetate treatment (group P) and the onion extract treatment (group O) than control
(group C). And, the total intensity of green color was significantly higher in the
TGF-β1 treatment (group T) than the group C. a, b, cValues with a different
superscript were significantly different (P<0.05).
The total intensity of green color was significantly lower in the prednisolone
acetate treatment (group P) and the onion extract treatment (group O) than control
(group C). And, the total intensity of green color was significantly higher in the
TGF-β1 treatment (group T) than the group C. a, b, cValues with a different
superscript were significantly different (P<0.05).
DISCUSSION
Formation of corneal haze involves the apoptosis of keratocytes [30] and transdifferentiation of keratocytes into myofibroblasts in
response to endogenous epithelial derived cytokines [16]. TGF-β1 directly activates keratocytes and leads to the formation of
myofibroblasts as well as the subsequent reformation of subepithelial stromal tissue [26]. Myofibroblasts scatter more light than that of
undifferentiated fibroblasts or keratocytes, not only from their nuclei, but also from their
cell bodies and dendritic processes [23]. In
addition, this population of cells participates in extracellular matrix remodeling,
resulting in a denser and more disorganized extracellular matrix [15]. Intracellular microfilament fibers, such as F-actin and α-smooth
muscle actin (SMA), were expressed much higher in myofibroblasts than in keratocytes. These
cellular components were enabled myofibroblasts to contract and close wounds, but also
rendered the cornea less translucent [19].
Collectively, these changes lead to a loss of corneal transparency.For a clear cornea, mitomycin C (MMC) is widely used intraoperatively by clinicians to
prevent PRK-induced corneal haze, although there are several complications reported with its
topical use [3]. There are no effective medicines to
control corneal haze, except for MMC treatments. Because the application of steroid eye drop
occasionally results in rapid corneal stromal melting, use of these drugs for achieving
better corneal transparency is restricted. Thus, we have shown the effects of onion extract
ointment in corneal haze prevention and suppression of myofibroblasts from stromal ablation
using the air assisted lamellar keratectomy for the development of new treatment and
prevention strategies. Corneal fibroblasts were viable in the 10
µl/ml concentration of the onion extract. There were no
adverse effects or allergic reactions for the 1% onion extract ointments. Therefore, we used
this concentration of onion extract ointments in this study to evaluate efficacy of onion
extract. According to our results, corneal haze grading and expression of α-SMA-positive
cells were significantly decreased in the onion extract treated group compared with the
control group. Because α-SMA is a specific marker for myofibroblasts, these results suggest
that onion extract ointment has suppressive effects on corneal haze.Treatment with prednisolone acetate showed significant suppression of corneal haze compared
with the artificial tear treatment in this paper. Postoperative use of topical
corticosteroids has been controversial after PRK. Topically applied steroids, acting as an
anti-inflammatory agent, have effectively suppressed corneal haze formation after excimer
laser keratectomy in experimental studies [17, 24]. But, this reduction in haze appears to be due in
part to a delay in the wound-healing response [24].
Also, glucocorticoids increase the lytic action of corneal collagenase, suggesting that this
effect might be responsible for the corneal destruction in clinical conditions [2]. Accordingly, the onion extract ointment could be used
more safely than steroid eye drops, which would be induced corneal melting.Onion (Allium cepae) extract contains a great amount of antioxidant
phytochemicals, sulfur and other numerous phenolic compounds [1]. These compounds have been reported to be effective in cardiovascular diseases
because of their hypolipidemic, anti-hypertensive, anti-diabetic and antithrombotic effects,
and to possess many other biological activities including antimicrobial, antioxidant,
anticarcinogenic, antimutagenic, antiasthmatic, immunomodulatory and probiotic activities
[6]. Especially, onion extract was shown to have
fibroblast-inhibiting properties, to reduce proliferative activity, and to produce
substances in the extracellular matrix [13].
Recently, commercial products composed of onion extract have been used to reduce scar
formation on the skin [13]. According to the results
of this paper, onion extract suppressed the differentiation of myofibroblasts, and as a
result, corneal haze developed significantly less than that of the control. Onion extract
would be a good therapeutic candidate as a new medicine for corneal haze suppression.Mechanical removal of the corneal epithelium and PRK up-regulate TGF-β1 [11]. TGF-β1, a potent profibrotic cytokine, is a key
regulator for the differentiation of myofibroblasts during corneal wound healing. It
directly activates keratocytes and leads to the formation of myofibroblasts as well as the
subsequent reformation of the subepithelial stroma [11]. Consequently, these mechanisms could promote the clinical expression of
corneal haze after corneal surgery. In our results, corneal haze was significantly increased
by treatments of additional TGF-β1 compared with the control. Furthermore, one experiment
showed the prevention of PRK-induced haze through the use of anti-TGF-β1 antibodies [22]. Thus, the suppression of TGF-β1 expression is
critical in the prevention of corneal haze.Fibroblasts differentiate into myofibroblasts through a Smad 2/3 signaling pathway and
enhance NADPH oxidases (Nox) 4-derivedreactive oxygen species (ROS) signaling cascades
[7]. Depletion of Nox4, an essential mediator of
Smad2/3 transcription factor activation in response to TGF- β1, down-regulates α-SMA mRNA,
and overexpression of Nox4 induces α-SMA expression [5]. The precise mechanisms of onion extract have not yet been completely elucidated.
The corneal haze grade was significantly lower in the onion extract treated group than in
the control group, and the expression of α-SMA was also down-regulated by the onion extract
treatments shown in the results of this study. Among the many flavonoid compounds, quercetin
is a major component of onion extract [27], and it
has been shown to have powerful antioxidative activity with metal ion binding properties and
radical scavenging abilities [9]. In addition,
quercetin has a scavenging effect on superoxide anions and hydroxyl radicals, and it
prevents lipid peroxidation by blocking the action of xanthine oxidase and chelating iron
[14]. These effects could have important roles in
the suppressive effect of onion extract against corneal haze formation. These results
suggest that onion extract could block TGF-β1 signaling cascades by scavenging ROS to reduce
α-SMA expression and subsequently corneal haze development. Further experiments are needed
to understand the exact mechanisms of onion extract.The limitation of this study is that the evaluation time was short and there was not enough
to prove exact mechanism of onion extract ointment against corneal haze formation.
Therefore, more studies will be needed to understand the mechanisms.In summary, onion extract ointment could be useful as the therapeutic in the suppression of
corneal haze development after applying the air assisted lamellar keratectomy through the
down-regulation of fibroblast transdifferentiation into myofibroblasts. This effect could be
from the scavenging ability of the onion extract.
Authors: Ioan Cucoranu; Roza Clempus; Anna Dikalova; Patrick J Phelan; Srividya Ariyan; Sergey Dikalov; Dan Sorescu Journal: Circ Res Date: 2005-09-22 Impact factor: 17.367
Authors: Rangan Gupta; Benjamin W Yarnall; Elizabeth A Giuliano; Jagat R Kanwar; Dylan G Buss; Rajiv R Mohan Journal: Vet Ophthalmol Date: 2011-04-18 Impact factor: 1.644
Authors: Roza E Clempus; Dan Sorescu; Anna E Dikalova; Lily Pounkova; Patricia Jo; George P Sorescu; Harald H H Schmidt; Bernard Lassègue; Kathy K Griendling Journal: Arterioscler Thromb Vasc Biol Date: 2006-11-02 Impact factor: 8.311
Authors: Ajay Sharma; Maneesh M Mehan; Sunilima Sinha; John W Cowden; Rajiv R Mohan Journal: Invest Ophthalmol Vis Sci Date: 2009-01-24 Impact factor: 4.799